/
/
/

Gujarat Kidney And Super Speciality Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
₹34 Cr₹31 Cr₹23 Cr₹13 Cr₹15 Cr₹10 Cr₹12 Cr₹9 Cr
₹69 L₹71 L₹6 L₹9 L₹80,000₹5 L₹5 L₹5 L
₹35 Cr₹31 Cr₹23 Cr₹13 Cr₹15 Cr₹10 Cr₹12 Cr₹9 Cr
₹27 Cr₹26 Cr₹18 Cr₹9 Cr₹8 Cr₹8 Cr₹8 Cr₹5 Cr
₹9 Cr₹7 Cr₹7 Cr₹5 Cr₹9 Cr₹3 Cr₹5 Cr₹5 Cr
₹66 L₹82 L₹60 L₹28 L₹18 L₹16 L₹17 L₹16 L
₹7 Cr₹5 Cr₹5 Cr₹4 Cr₹7 Cr₹2 Cr₹4 Cr₹4 Cr
₹5 Cr₹5 Cr₹4 Cr₹3 Cr₹5 Cr₹1 Cr₹3 Cr₹3 Cr

Share Price Live Stats

Open (₹)186.78
Volume (₹)9.84 L
High (₹)196.18
Upper Circuit223.02
Low (₹)185.12
Lower Circuit148.68
Prev Close185.85
52W High (₹)209.80
Price194.69
52W Low (₹)98.36

Share Market Cap & Key Ratios Overview

M.Cap (₹)1465.30 Cr
Div. Yield (%)0.00
PE Ratio92.54
Debt to Equity0.06
Price to Book3.16
Book Value32.03
EPS (TTM)2.01
Face Value2.00
ROE (%)12.08

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
APOLLOHOSPNSE
MANIPALHOSNSE
MAXHEALTHNSE
ASTERDMNSE
FORTISNSE
NHNSE
MEDANTANSE
LALPATHLABNSE
KIMSNSE
AGARWALEYENSE
GKSLNSE
LTP
1W Low
1W High
Market cap (₹)
7824-203.5 (-2.54%)
7688
8100
1,13,202Cr
650.05-51.25 (-7.31%)
647
707.05
87,861Cr
852.5-31.3 (-3.54%)
842.05
894.80
84,036Cr
675.2-24.65 (-3.52%)
673.30
706.30
60,058Cr
750-36.25 (-4.61%)
737.95
785.55
57,075Cr
1689.4-30.1 (-1.75%)
1663.50
1731.80
34,466Cr
1280-32.7 (-2.49%)
1257.50
1322.10
34,447Cr
1938+4.4 (0.23%)
1887.10
2002.50
32,084Cr
692.95-12.55 (-1.78%)
685.15
718.20
29,768Cr
467-10.75 (-2.25%)
463.45
480.95
14,956Cr
194.69+10.6 (5.76%)
181.21
196.18
1,465Cr

Key Highlights of Gujarat Kidney And Super Speciality Ltd’s P&L

In 2025-03-31, Gujarat Kidney And Super Speciality Ltd reported total revenue of ₹40.4Cr, compared with ₹5.48Cr in 2024-03-31, reflecting Gujarat Kidney And Super Speciality Ltd turnover.

Depreciation was ₹3.29Cr and finance costs were ₹64.63Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹12.77Cr in 2025-03-31 as compared to ₹2.27Cr in 2024-03-31.

Net Profit (PAT) was ₹9.41Cr in 2025-03-31 compared with ₹1.71Cr in 2024-03-31.

Earnings per share (EPS) were ₹1.66 in 2025-03-31, compared with ₹85.70 in 2024-03-31.